Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent
responsible for the COVID-19 pandemic, has outspread at full tilt across the world. Although …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a new coronavirus in
the Coronaviridae family. The COVID-19 pandemic, caused by SARS-CoV-2, has …

Background: Cough is a wearisome and exasperating symptom affecting the daily life of the
infected patient. Cough due to coronavirus disease 2019 (COVID-19) causes excessive …

Background Several studies have shown that the risk of mortality due to COVID-19 is high in
patients with COPD. However, evidence on factors predicting mortality is limited. Research …

Background The successful management of patients infected with coronavirus disease 2019
(COVID-19) with inhaled ciclesonide has been reported, however few studies have …

The current coronavirus disease 2019 (COVID-19) outbreak spread rapidly worldwide. Yet,
there is no identifiable antiviral treatment, so an effective drug is urgently needed. Preventive …

Abstract Background Coronavirus disease 2019 (COVID‐19) causes a variety of cough
symptoms in the acute and chronic phases. Chikujountanto (CUT) is a Kampo formula …

Few studies have investigated the risks of developing intubation and death in patients seen
in the ED with COVID-19 and pre-existing asthma. We conducted a retrospective cohort …

Представлен анализ 46 публикаций, посвященных применению ИГКС при COVID-19.
Представлены как результаты исследований, так и их обсуждение специалистами …

Аннотация Представлен анализ 46 публикаций, посвященных применению ИГКС при
COVID-19. Представлены как результаты исследований, так и их обсуждение …